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Two faces of differentiated β 
cells
Insulin release is regulated as a function 
of nutritional supplies and metabolic 
demands, both of which fluctuate over 
time and depend on physical activity, preg-
nancy status, age, and a variety of other 
factors. As too little or too much circulat-
ing insulin can be harmful, mature β cells 
are equipped with an efficient delivery 
apparatus that rapidly mobilizes a fraction 
of stored insulin within secretory granules 
via the secretory pathway (1). Moreover, β 
cells possess a precise metabolic detection 
system (Figure 1) that couples the extra-
cellular glucose concentration to the rate 
of secretory granule exocytosis (2). Sev-
eral of these critical phenotypic features 
are acquired shortly after birth, when β 
cells mature (3). The transition from the 
neonatal to the adult β cell involves not 
only upregulation of genes — such as the 
transcription factor MAFA and insulin 
genes, required for the specialized tasks 
of β cells — but also repression of a set of 
genes that are detrimental to pancreatic 
islet formation and are widely used in 
other mammalian cell types (4). The scale 
of this tissue-specific repression (a phe-
nomenon referred to as disallowed genes) 
was examined by genome-wide analyses 
that compared gene expression in adult 
islets of Langerhans with a panel of other 
tissues (4, 5). By looking at the overlap 
between the above-mentioned microar-
ray studies, Pullen and Rutter identified 
a core set of about 10 disallowed genes in 
pancreatic islets (6). Among the genes in 
this core set are those encoding the lactate 
pyruvate transporter MCT1 (also known 
as SLC16A1) and lactate dehydrogenase A 
(LDHA). MCT1 and LDHA closely collabo-
rate (Figure 1) to allow anaerobic glycolysis 
in most tissues and cells.
It is known that β cells avoid anaerobic 
glycolysis during metabolic glucose sensing 
(7). Instead, normal β cells funnel glucose to 
mitochondrial pyruvate uptake and metab-
olism (8). The selective absence of MCT1 
in β cells explains why insulin secretion is 
unresponsive to a rise in extracellular pyru-
vate, a situation that is reversed in individ-
uals with a Mendelian disorder called exer-
cise-induced hyperinsulinism (9), which 
results from loss of regulation at the level of 
the human MCT1 promoter (10). The pres-
ence of MCT1 in β cells would confuse the 
physiology of glucose homeostasis in that β 
cells would no longer discriminate elevated 
glucose (after meals) from elevated pyru-
vate (after exercise) and would therefore 
fail to match circulating insulin levels to 
metabolic demands (Figure 1).
Although the number of genes specif-
ically repressed in islets is low, the scale 
of the phenomenon increases when genes 
that are repressed not only in islets but also 
in one or two additional tissues are consid-
ered. One example is the group of low-Km 
hexokinases (HK1–HK3), which catalyze 
the first step of glycolysis in most cells. 
For pancreatic β cells and hepatocytes, 
however, these isoforms are ill adapted to 
sustain glucose homeostasis because they 
are saturated by micromolar amounts of 
their substrate glucose. In contrast, glu-
cokinase (GK, Figure 1) is well adapted for 
precise control of glucose homeostasis, as 
its enzymatic affinity for glucose is in the 
millimolar range (11). β Cells efficiently 
repress HK1, and what little enzymatic 
activity that has been measured in islets 
was attributed to contaminating exocrine 
pancreatic cells (12). Forced expression of 
low-Km HK1 in β cells (13) elevates basal 
insulin secretion, rendering β cells dan-
gerous in terms of hypoglycemic risk (Fig-
ure 1). Hk1, Ldha, and Mct1 therefore rep-
resent examples of a class of disallowed 
genes (14) that would jeopardize normal β 
function when expressed (15).
The start of an epigenetic 
roadmap
How do β cells selectively repress genes 
that are active in most other cell types? 
Epigenetic-based mechanisms have been 
suggested in earlier work. Thorrez et al. 
detected repressive chromatin markers in 
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Pancreatic β cells support glucose homeostasis with great precision by 
matching insulin release to the metabolic needs of the moment. Previous 
gene-expression analysis indicates that adult β cells not only produce cell-
specific proteins, but also repress a small set of housekeeping genes — such 
as those encoding lactate dehydrogenase A (LDHA), solute transporter 
MCT1, and hexokinase 1 (HK1) — that would otherwise interfere with normal 
β cell function. In this issue of the JCI, Dhawan et al. elucidate a molecular 
mechanism involved in β cell–specific repression of Ldha and Hk1 that is 
mediated by induction of the de novo DNA methyltransferase DNMT3A 
during the first weeks after birth. Failure to induce DNMT3A-dependent 
methylation disrupts normal glucose-induced insulin release in adult life. 
The results of this study reinforce the idea that the phenotype of adult β 
cells has two faces and that failure to achieve selective gene repression 
undermines β cell support of normal glucose homeostasis.
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had elevated basal plasma insulin and a 
poor insulin response after i.p. glucose 
injection, and isolated islets from these 
animals were deficient for glucose-in-
duced insulin release. The Hk1 and Ldha 
loci were weakly methylated in β cells of 
3aRCY-KO mice, resulting in upregula-
tion of Hk1 and Ldha transcripts. More-
over, siRNA-mediated knockdown of Hk1 
and Ldha transcripts partially restored 
insulin secretory competence in 3aRCY-
-KO β cells. Comparison of adult human 
pancreatic islets with immature, insulin-
expressing cells derived from pluripotent 
cells revealed higher levels of DNA meth-
ylation and stronger repression of HK1 
and LDHA in the mature islets. Together, 
the study by Dhawan et al. (18) supports 
the importance of disallowed gene repres-
encoding key β cell factors, including 
MAFA and GK (Figure 1), with a concur-
rent downregulation of Hk1, Hk2, Aldob, 
and Ldha. Evaluation of methylated versus 
nonmethylated cytosines in the Hk1 and 
Ldha gene loci demonstrated that there 
is a net increase in methylation of these 
2 loci between P4 and P25. ChIP anal-
ysis showed that the DNA methyltrans-
ferase DNMT3A is maximally enriched 
at the Ldha and Hk1 loci in β cells two 
weeks after birth. Dhawan and colleagues 
developed a mouse strain with a β cell–
specific deletion of Dnmt3a (Dnmt3afl/fl 
R26R-eYFP RIP-Cre mice, referred to as 
3aRCY-KO) that allowed for direct evalu-
ation for the role of DNMT3A in the meth-
ylation and repression of Hk1 and Ldha. 
Compared with controls, 3aRCY-KO mice 
a few of the genes repressed in β cells (4). 
A more systematic, genome-wide analysis 
of histone H3 modifications (16) showed 
that β cell maturation is associated with 
both activation and inactivation of spe-
cific genes. In a follow-up study, the poly-
comb repressor complex subunit RING1B 
was identified as one of the molecular 
components that mediate these epige-
netic changes (17).
In this issue (18), Dhawan and col-
leagues propose that the de novo DNA 
methyltransferase DNMT3A plays an 
important role in mediating epigenetic 
gene repression during β cell maturation. 
Analysis of mRNA expression in FACS-pu-
rified β cells from MIP-GFP mice revealed 
that between postnatal days 4 and 25 (P4 
and P25), there is an upregulation of genes 
Figure 1. DNMT3A mediates repression of genes that disrupt normal glucose-regulated insulin release in β cells. (A) Physiological, nutrient-induced insulin 
release during a carbohydrate-containing meal depends on the expression of key proteins in pancreatic β cells that couple a rise in circulating glucose to an 
accelerated metabolic flux, leading to an increased [ATP]/[ADP] ratio, closure of ATP-sensitive potassium channels and a rise in cytosolic calcium  
(1), and appropriate levels of insulin secretion that support normoglycemia. In this issue, Dhawan et al. (18) show that the DNA methyltransferase DNMT3A 
is critical for repression of disallowed genes Hk1 and Ldha that would otherwise interfere with β cell function. The factors that induce and maintain DNMT3A 
in β cells have not been fully elucidated. (B) Inappropriate insulin secretion, as in too much insulin under basal conditions or activation of induction of 
secretion by nonphysiological stimuli, can cause hypoglycemia (15). In the absence of DNMT3A, expression of HK1 elevates basal insulin release because 
the enzyme has a high affinity for its substrate glucose, and elevated LDHA promotes conversion of lactate into pyruvate. Moreover, increased levels of the 
pyruvate transporter MCT1 promote inappropriate insulin secretion (10). Dhawan and colleagues show that murine β cells switch off Hk1 and Ldha expression 
when cells mature the first weeks after birth, as the result of DNMT3A-mediated cytosine methylation (yellow circles) in the Hk1 and Ldha gene promoters.
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insulin release. Because DNMT3A acts as a 
de novo methylase that introduces an epi-
genetic landscape in newly replicated cells 
(22), adult, nonreplicating, β cells may uti-
lize other mechanisms to maintain appro-
priate gene-expression patterns. For exam-
ple, a cytosine demethylation pathway that 
is mediated by a family of Tet dioxygenases 
(23) can reactivate expression of methy-
lated loci, but the activity of these enzymes 
has not been studied in adult β cells. Future 
studies should also address a potential role 
for β cell microRNA that may interfere with 
DNMT3A activity, in particular members 
of the miR-29 family (24).
It should be noted that Dhawan et al. 
(18) used the MIP-GFP and RIP-Cre 
mouse models, which harbor an artificial 
human growth hormone (hGH) minigene 
that is expressed in transgenic islets (25). 
Expression of the hGH minigene likely 
does not alter repression of disallowed 
genes, as hGH does not influence these 
genes in Pdx1-Cre mice (25). It is not clear 
why methylation at the Mct1 promoter was 
not affected by Dnmt3a KO, as Mct1 has 
clear H3K27me3 marks in differentiated β 
cells (4). Is it possible that complementary 
methyltransferases act on a different set 
of disallowed target genes?
Together, the study by Dhawan et al. 
(18) supports the earlier idea that β cell 
differentiation has two faces (4): a visible 
face that shows accumulation of specific 
β cell proteins and a hidden face that pro-
tects β cells against ubiquitous proteins 
that need to be repressed to prevent dis-
turbance of normal β cell function. The 
facets of both faces need to be addressed 
in efforts to generate insulin-producing 
cells from pluripotent stem cells. Dha-
wan and colleagues (18) propose that 
DNMT3A is one of the waypoints in the 
epigenetic roadmap of β cell maturation 
that is essential for the transition from 
immature to mature β cells. Evaluation of 
the roles of DNMT3A in preventing β cell 
abnormalities during chronic metabolic 
disease would appear to be interesting 
topics for future studies.
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sion for normal β cell function. Addition-
ally, these results provide an explanation 
for how maturing β cells switch off a set 
of genes that would destroy normal func-
tion when expressed and show that the de 
novo methyltransferase DNMT3A plays 
an active role in this process.
New questions
The study by Dhawan and colleagues 
on DNMT3A (18) and previous work on 
RING1B (17) can be viewed as starting 
points that provide important fragments of 
information for compiling a more complete 
epigenetic roadmap (19) of neonatal imma-
ture β cells and adult mature β cells. It will be 
interesting to elucidate how DNMT3A activ-
ity in β cells is regulated and how the meth-
yltransferase is guided toward its epigenetic 
target regions. One possibility is that histone 
H3K27 tri-methylation (H3K27me3), which 
is associated with polycomb repression, is 
a context-dependent chromatin signal that 
guides DNMT3A activity toward its relevant 
target genes (20). This raises the question 
of how H3K27me3 marks are selectively 
introduced in the disallowed target genes 
of maturing β cells. Interestingly, not only 
were Hk1 and Ldha upregulated in 3aRCY-
-KO β cells, but expression of key β cell 
genes, including Mafa, Pdx1, and Gk, was 
reduced, indicating that these two phenom-
ena are interconnected. It seems possible 
that some of the β cell–specific transcription 
factors that enhance expression of a set of β 
cell genes could also operate as repressors 
in a context-dependent manner. Future 
experiments should address the precise link 
between repression of disallowed genes and 
upregulation of β cell genes.
It should also be noted that the neona-
tal period of DNMT3A activity is a contin-
uation of intrauterine events that initiate β 
cell identity via DNA methylation (21). This 
raises the question as to whether or not envi-
ronmental conditions during pregnancy 
influence the starting position of neonatal 
epigenetic events. Moreover, what happens 
after β cells have matured? How is the con-
tinued repression of disallowed genes at 
the end of the neonatal period maintained? 
Adult β cells are essentially a nonrepli-
cating population, yet they remain active 
during the entire lifetime of rodents and 
humans. Therefore, it seems relevant to 
assess the impact of environmental factors, 
such as a high-fat diet, that elevate basal 
Downloaded from http://www.jci.org on November 13, 2015.   http://dx.doi.org/10.1172/JCI82575
The Journal of Clinical Investigation C omm e n ta ry
2 5 6 8 jci.org   Volume 125   Number 7   July 2015
development. Cell. 1999;99(3):247–257.
 23. He YF, et al. Tet-mediated formation of 5-carboxy-
lcytosine and its excision by TDG in mammalian 
DNA. Science. 2011;333(6047):1303–1307.
 24. Fabbri M, et al. MicroRNA-29 family reverts 
aberrant methylation in lung cancer by targeting 
DNA methyltransferases 3A and 3B. Proc Natl 
Acad Sci U S A. 2007;104(40):15805–15810.
 25. Brouwers B, et al. Impaired islet function in 
commonly used transgenic mouse lines due to 
human growth hormone minigene expression. 
Cell Metab. 2014;20(6):979–990.
Nature. 2015;518(7539):317–330.
 20. Rose NR, Klose RJ. Understanding the relation-
ship between DNA methylation and histone 
lysine methylation. Biochim Biophys Acta. 
2014;1839(12):1362–1372.
 21. Dhawan S, Georgia S, Tschen SI, Fan G Bhushan 
A. Pancreatic β cell identity is maintained by 
DNA methylation-mediated repression of Arx. 
Dev Cell. 2011;20(4):419–429.
 22. Okano M, Bell DW, Haber DA, Li E. DNA meth-
yltransferases Dnmt3a and Dnmt3b are essen-
tial for de novo methylation and mammalian 
allows insulin-producing β-cells to adopt a 
neural gene activity program. Genome Res. 
2010;20(6):722–732.
 17. van Arensbergen J, et al. Ring1b bookmarks 
genes in pancreatic embryonic progenitors 
for repression in adult β cells. Genes Dev. 
2013;27(1):52–63.
 18. Dhawan S, et al. DNA methylation directs func-
tional maturation of pancreatic β cells. J Clin 
Invest. 2015;215(7):2851–2860.
 19. Roadmap Epigenomics Consortium, et al. Integra-
tive analysis of 111 reference human epigenomes. 
Downloaded from http://www.jci.org on November 13, 2015.   http://dx.doi.org/10.1172/JCI82575
